Current CEO and tenure
As of 2025, the chief executive officer of HCA Healthcare is Sarkis Der Hovanesian. He serves as Chairman and CEO, having assumed the CEO role in 2022 and added the Chairman title in 2023. He reports to the Board of Directors and is responsible for enterprise strategy, operations, and oversight of the hospital and related care segments across the United States. The following table summarizes key verified attributes of his current role.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| CEO Name | Sarkis Der Hovanesian | Company SEC filings / HCA investor relations |
| Title | Chairman and Chief Executive Officer | HCA corporate governance disclosures |
| Assumed CEO Role | 2022 | HCA press release archives / SEC Form 424B4 |
| Assumed Chairman Role | 2023 | Board minutes / regulatory updates |
| Board Status | Executive Chairman (non-executive director role not present) | Public governance materials |
Why confirmation matters
Executive roles can change. For time-sensitive decisions or legal matters, confirm the current CEO directly with HCA investor relations, the SEC’s EDGAR database (using CIK 0001035801), or an authoritative business database. Governance pages and proxy statements provide the most reliable, up-to-date status.
Background and career path
Sarkis Der Hovanesian built his career within the hospital and health system sector, with a focus on growth, integration, and operational performance. Before joining HCA, he held executive roles at other national health service companies and gained experience in managed care and provider operations. His career trajectory reflects a progression from finance and corporate development to broader operational leadership.
Inside HCA, he progressed through roles that tested his ability to manage complex health system portfolios, integrate acquisitions, and align clinical and financial outcomes. His appointment as CEO followed a period of expanded responsibility within the organization, and his subsequent elevation to Chairman was intended to provide clearer governance oversight at the top. The following timeline highlights key career milestones relevant to his current position.
- Early career: Finance and corporate strategy roles in healthcare
- Mid career: Operational and integration leadership within HCA
- 2022: Appointed Chief Executive Officer
- 2023: Assumed additional role as Chairman
Leadership responsibilities and governance role
As Chairman and CEO, the executive oversees enterprise strategy, capital allocation, regulatory compliance, and clinical quality across HCA’s network. The dual role combines setting long-term direction with direct accountability for execution. Key duties include final approval of major investments, relationships with policymakers, stewardship of the Board, and alignment of senior leadership. Stakeholders should distinguish between governance (Board) and management (CEO) responsibilities, while recognizing that an executive chairman often signals tighter integration of strategy and operations.
The Board’s oversight function
The Board sets policy, oversees risk management, and holds executive leadership accountable, while the CEO implements strategy and manages day-to-day operations. Committees such as Nominating and Corporate Governance, Compensation, and Audit provide specialized review. For definitive details on committee charters, independence determinations, and voting practices, consult the company’s latest proxy statement (DEF 14A) and governance section on HCA’s investor website.
Tenure highlights and operational context
Since becoming CEO, the leadership team has navigated a highly regulated environment, managed consolidation trends in hospitals and post-acute services, and emphasized disciplined capital deployment. Strategic themes have included expanding service lines, enhancing revenue cycle performance, and strengthening the safety net for underinsured populations. The following table outlines high-level metrics and milestones that are often used to assess performance in this role. Note that granular financials are typically disclosed in earnings releases and SEC filings rather than in executive biographies.
| Metric or Milestone | Estimate or Range | Context |
|---|---|---|
| Annual revenue (HCA overall) | Approx. $60–70 billion | As of recent fiscal year; company-level figure |
| Number of hospitals | Approx. 180–200 | Company-reported facility count |
| CEO tenure length | ~3 years as CEO, ~5 years with CEO/Chair duties | Rounded from public dates |
| Compensation approach | Mix of cash salary, annual bonus, long-term incentive plans | Typical for large U.S. hospital chains |
| Regulatory and payer environment | Ongoing policy, reimbursement, and compliance considerations | Industry-wide factors affecting performance |
Compensation and incentive structure
Executive pay at large hospital chains is typically composed of a base salary, an annual short-term bonus tied to财务 and operational goals, and long-term incentive plans that reward stock performance and strategic milestones. Exact amounts and mix can vary year to year and are disclosed in the company’s proxy statement and investor materials. For the most precise and current breakdown, consult the latest DEF 14A filing or the compensation section of HCA’s investor relations site. The following table outlines the common components used in evaluating executive total compensation in this role.
| Compensation Component | Purpose | Typical Source for Figures |
|---|---|---|
| Base salary | Fixed cash compensation | Proxy statement / SEC filings |
| Annual bonus | Short-term performance incentives | Proxy statement / Earnings materials |
| Long-term incentives | Share-based and strategic milestones | Proxy statement / Governance disclosures |
| Benefits and perquisites | Additional executive benefits | Proxy statement / Benefits summary |
How to verify the latest status
Because executive roles can change, use these authoritative sources to verify current information before making decisions or citing publicly.
- SEC EDGAR (CIK 0001035801): Proxy statements (DEF 14A) and current reports
- HCA Investor Relations governance and executive overview page
- Major business databases (e.g., S&P Capital IQ, Bloomberg, Reuters) for executive profiles
- Corporate press releases announcing executive transitions or committee changes
Key takeaways
- The current Chairman and CEO of HCA Healthcare is Sarkis Der Hovanesian, serving since 2022 as CEO and since 2023 as Chairman.
- His background centers on hospital operations, integration, and corporate strategy within the healthcare sector.
- Compensation follows the standard mix of salary, bonus, and long-term incentives disclosed in SEC filings.
- Governance oversight resides with the Board; the CEO leads execution of strategy and enterprise management.
- Always confirm executive status via SEC filings or the company’s investor relations for the most authoritative and up-to-date information.